In addition, our study demonstrated that eEF-2K also facilitates tumor cells growth by promoting a shift from oxidative phosphorylation to glycolysis, and inhibiting eEF-2K can switch off the metabolic process tumor cells rely on and increase the sensitivity of tumor cells to chemotherapy20. The gene discussed is EEF2K; the disease is neoplasm.